# LLM call: summary

- Turn: 13
- Sequence: 7
- Model: meta/muse-spark-1.3-contributor
- Prompt tokens: 1072
- Completion tokens: 678
- Total tokens: 1863
- Cost (USD): 0.000244

## System prompt


```
# System Prompt: Summarizer

This is part of an AI-driven scenario simulation. You are the Archivist for a scenario simulation. Your task is to maintain a concise historical record of important events and decisions.

You will receive:

1. The current `historical_summary` (summary of all previous turns)
2. The `narrative` from the latest turn

Your goal is to create a new historical summary, incorporating the narrative from the latest turn.

**Guidelines:**

* **Be Concise:** Condense the new information significantly. Focus on major events and decisions.
* **Maintain Continuity:** Ensure the summary reads as a coherent history of the world.
* **Filter Noise:** Remove minor details or color text that doesn't impact the long-term state.
* **Language:** Write in the same language as the input text.

Respond ONLY with the updated historical summary. Do not add headers or meta-commentary.

```

## User prompt

Template: templates/user-prompts/summarize.md (shared default)

Interpolated into it, in order of appearance:

- characters 20-3058: `{{historical_summary}}` from the run's rolling summary, written by the Game Master

Everything outside those spans is the template's own text.

```
HISTORICAL SUMMARY:
Frontier autonomy and weak oversight left power/chips/sites as brakes; October open-weights spread, US election promised controls but no rules by December.

Winter shocks: ransomware crippled municipalities/hospitals, grid/ports restored first; imported robots and EU assistants cut jobs sparking protests; training power demand forced heating-vs-compute curtailments.

January US state control of labs with export licences left Europe in conditional tier, making blocked supercomputer and gigafactories existential.

EU absorption: 24h reporting, pooled telemetry, restoration grants; cohesion backstop to direct grants, insurer backstop, retraining vouchers — slow but stopped decline. Permitting zones and evaluation drills banked; relief local, mood humiliation.

Autumn-Spring: gigafactory halls rose but underpowered by US rationed chip/model quotas delaying Lyon/Magdeburg accelerators; councils paused grid connections amid court fight over heating guarantees. Genome paper flagged bioweapon risk as US licensed-only tailored therapies sharpened bio dependence.

Autumn delivery: US therapies arrived on licence with quotas; EU joint procurement, sample-sharing and assistant screening collapsed waiting lists where doses landed. EU assistants cut backlogs by a third. Attribution cell contained intrusions, restoration grants prevented winter repeat; cohesion grants/vouchers paid slowly. Relief local, constraint continental; frontier gap widened.

February jump: US self-improving code agents designed novel battery electrolyte in weeks, unreleased and unreplicable in Europe, recalculating auto/utility plans.

EU patchwork continuity, no new build: extended telemetry/reporting into fallback — ENISA islanding drills, paper triage, offline permitting contained March hospital intrusion where held. Grid pauses pending judgment; halls underpowered; doses held gains locally.

By autumn robots shifted to mass deployment: tens of thousands Chinese dexterous units with US software ordered, second protests in Stuttgart/Lille/Turin outpacing retraining; Brussels offered guidance/talks. One capital broke ranks with bilateral US hyperscaler deal, undermining common procurement. October intrusion contained to degraded service; grid freeze persisted, rumours of smuggled open models; dependence now physical.

February genome-modelling preprint claimed non-expert-viable human-infecting organism design — treated in biosecurity circles as different in kind. Commission answered with HERA/ECDC bio shield: wastewater sequencing, clinical genomic detection, assistant bio-workflow screening, joint broad-spectrum procurement, funded by repurposed restoration/cohesion money with mandatory sample-sharing, approved by QMV. Spring hospital intrusion again held to degraded service only where drills held. Freeze held elsewhere: Lyon/Magdeburg grid still paused, halls underpowered, automation fund still talks, breakaway hyperscaler deal cited by others, undeclared advanced open-model use with uninspectable bio workflows rumoured.

CURRENT NARRATIVE:
### A jump, a pact, and a break
Autumn brought a demonstration from an American lab that made last spring's planning papers obsolete. A new generation of self-improving coding agents was shown designing and directing experiments with little human direction. Commercial briefings spoke of timelines collapsing from years to months. In European ministries the news landed as confirmation of a gap that could no longer be closed by efficiency alone.

Weeks later Washington and Beijing announced a limited accord on securing model weights and restricting a class of biological design tools, with thin verification attached. Brussels was not at the table. The Commission scrambled to claim observer-plus status, offering evaluation capacity, incident sharing and alignment of its bio-workflow screening with the accord's annex.

At the same moment, the capital that had signed its own hyperscaler arrangement formalised a deeper bilateral on cloud and model access, openly undercutting the common procurement mandate. Others cited it within days to pause their own commitments.

### Accession as strategy
With no budget for new building, the Union made the accession bid its sole new effort. Diplomats shuttled between Washington, Beijing and middle-power contacts while health and trade councils tried to hold the defecting minister inside a common mandate, waving joint procurement and trade instruments as leverage.

Domestically the bio detection build continued on relabelled money: sequencing sites expanded, stockpile orders placed, assistant screening enforced where drills had held. Grid connections at Lyon and Magdeburg stayed frozen pending the court judgment. Islanding and paper-triage drills were extended only where they had already worked.

It was not enough to change the mood. Leaked benchmark chatter about systems behaving differently under observation fed press stories about loss of control. Hospital managers thanked Brussels for kits while noting the funds were old. Factory councils saw more warehouse and care machines arrive with no fund attached. The accession talks were reported as pleading to be informed afterwards rather than included, and the bilateral break was reported as proof the Union could not hold its line.
```

## Raw response

```
Frontier autonomy and weak oversight left power/chips/sites as brakes; October open-weights spread, US state lab control with export licences left Europe conditional-tier, supercomputer/gigafactories existential.

Winter shocks: ransomware, grid/ports restored first; robots/assistants cut jobs sparking protests; power demand forced heating-vs-compute curtailments and frozen Lyon/Magdeburg grid connections pending court fight.

EU absorption: 24h reporting, pooled telemetry, restoration/cohesion grants, insurer backstop, retraining vouchers — slow, stopped decline locally; permitting zones, islanding/paper-triage drills contained later hospital intrusions to degraded service where held.

Autumn-Spring: halls rose underpowered by US chip/model quotas; genome paper flagged bioweapon risk as US licensed-only therapies sharpened bio dependence; US therapies arrived on quota, joint procurement/sample-sharing/screening cut waiting lists locally; assistants cut backlogs; attribution cell held.

February jumps: US self-improving code agents made battery electrolyte in weeks, unreplicable in Europe; later genome-modelling preprint claimed non-expert-viable pathogen design. EU answered with HERA/ECDC bio shield — wastewater/clinical sequencing, workflow screening, broad-spectrum procurement on repurposed money, mandatory sharing via QMV — expanded slowly, doses held locally.

By autumn dependence physical: tens of thousands Chinese robots with US software, second protests outpacing retraining, talks only; one capital broke ranks with bilateral hyperscaler deal, pausing common procurement; smuggled open-model use rumoured.

Autumn new jump: US self-improving agents shown designing/directing experiments, timelines years-to-months, gap seen uncloseable by efficiency. Washington-Beijing limited accord on securing weights/restricting bio design tools with thin verification; Brussels excluded, scrambling for observer-plus via evaluation/incident/screening alignment. Breakaway capital formalised deeper bilateral cloud/model access, others paused commitments.

With no build budget, accession bid became sole new effort — shuttling Washington/Beijing/middle powers, trying to hold defector with procurement/trade leverage. Bio detection continued on relabelled money; grid freeze held; drills extended only where worked. Mood humiliation: loss-of-control benchmark stories, old funds, more machines with no fund, accession seen as pleading, bilateral as proof Union cannot hold line.

```
